Investing in equities in dividend-growth companies is a

Investing in equities in dividend-growth companies is a favored strategy amid moderate inflation. Utilities and telecom firms lead yield-based allocations, with average dividend hikes of 4% across top performers. I inherited a $30K trust. My bank says I’ll pay $10K in taxes if I cash out. Something is not right. Certain information contained in this content is believed to be reliable; however, J.P. Morgan does not represent or warrant its accuracy, reliability or completeness, or accept any liability for any loss or damage (whether direct or indirect) arising out of the use of all or any part of this content. No representation or warranty should be made with regard to any computations, graphs, tables, diagrams or commentary in this content, which are provided for illustration/reference purposes only. The views, opinions, estimates and strategies expressed in this content constitute our judgment based on current market conditions and are subject to change without notice. J.P. Morgan assumes no duty to update any information on this website in the event that such information changes. Views, opinions, estimates and strategies expressed herein may differ from those expressed by other areas of J.P. Morgan , views expressed for other purposes or in other contexts, and this content should not be regarded as a research report. Any projected results and risks are based solely on hypothetical examples cited, and actual results and risks will vary depending on specific circumstances. Forward-looking statements should not be considered as guarantees or predictions of future events. Latest earnings season strengthens the case for investing in equities in the healthcare sector. Biotechnology firms posted 18% revenue growth, and M&A activity is heating up, signaling broader consolidation that may push valuations higher in the next half-year.